PMID- 28638444
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 1758-5996 (Print)
IS  - 1758-5996 (Electronic)
IS  - 1758-5996 (Linking)
VI  - 9
DP  - 2017
TI  - Understanding the barriers and improving care in type 2 diabetes: Brazilian 
      perspective in time to do more in diabetes.
PG  - 46
LID - 10.1186/s13098-017-0244-y [doi]
LID - 46
AB  - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a complex disease, particularly in 
      a continental country like Brazil. We attempted to understand and evaluate the 
      perceptions and routines of Brazilians with T2DM and physicians, compared with 
      other countries. METHODS: We compared the results from a 20-min online survey in 
      Brazil with simultaneously collated data from India, Japan, Spain, UK and USA. 
      RESULTS: In total, 652 adults with T2DM and 337 treating physicians were 
      enrolled, of whom 100 patients and 55 physicians were from Brazil. The numbers of 
      primary care physicians from the five countries were 221 versus 43 in Brazil, 
      diabetes specialists were 61 versus 12. There was disconnect between the opinions 
      of physicians and people with diabetes globally. Further, there were differences 
      between clinical practices in Brazil versus the rest of the world, in many areas 
      Brazilians were performing better. CONCLUSIONS: Communication between patients 
      and physicians should be clearer. There is an urgent need to identify the 
      deficits in education, in order to address the clinical inertia within the 
      diabetes management team. There is a necessity to understand the specific 
      requirements of the Brazilian population in order to contextualise international 
      guidelines and implement local changes in practice.
FAU - Vencio, Sergio
AU  - Vencio S
AD  - Federal University of Goias-Postgraduate Programme, Goiania, Brazil. ISNI: 0000 
      0001 2192 5801. GRID: grid.411195.9
AD  - Avenida T-4 numero 313 Setor Bueno, Goiania, Goias CEP 74884-582 Brazil.
FAU - Paldanius, Paivi M
AU  - Paldanius PM
AD  - Novartis Pharma AG, Basel, Switzerland. ISNI: 0000 0001 1515 9979. GRID: 
      grid.419481.1
FAU - Bluher, Matthias
AU  - Bluher M
AD  - Department of Medicine, University of Leipzig, Leipzig, Germany. ISNI: 0000 0001 
      2230 9752. GRID: grid.9647.c
FAU - Giannella-Neto, Daniel
AU  - Giannella-Neto D
AD  - Uninove University, Sao Paulo, Brazil.
FAU - Caiado-Vencio, Rafael
AU  - Caiado-Vencio R
AD  - Catholic University of Goias, Goiania, Brazil.
FAU - Strain, W David
AU  - Strain WD
AD  - Diabetes and Vascular Medicine, University of Exeter Medical School, Exeter, UK. 
      ISNI: 0000 0004 1936 8024. GRID: grid.8391.3
LA  - eng
PT  - Journal Article
DEP - 20170615
PL  - England
TA  - Diabetol Metab Syndr
JT  - Diabetology & metabolic syndrome
JID - 101488958
PMC - PMC5472944
OTO - NOTNLM
OT  - Brazil
OT  - Clinical inertia
OT  - Diabetes
EDAT- 2017/06/24 06:00
MHDA- 2017/06/24 06:01
PMCR- 2017/06/15
CRDT- 2017/06/23 06:00
PHST- 2016/11/18 00:00 [received]
PHST- 2017/06/08 00:00 [accepted]
PHST- 2017/06/23 06:00 [entrez]
PHST- 2017/06/24 06:00 [pubmed]
PHST- 2017/06/24 06:01 [medline]
PHST- 2017/06/15 00:00 [pmc-release]
AID - 244 [pii]
AID - 10.1186/s13098-017-0244-y [doi]
PST - epublish
SO  - Diabetol Metab Syndr. 2017 Jun 15;9:46. doi: 10.1186/s13098-017-0244-y. 
      eCollection 2017.